An Open Label Clinical Trial of a Multi-Ingredient Anti-Aging Moisturizer Designed to Improve the Appearance of Facial Skin

July 2015 | Volume 14 | Issue 7 | Original Article | 699 | Copyright © July 2015


James H. Herndon Jr. MD,a Lily Jiang PhD,a Tatiana Kononov BS MBA,b Theresa Fox BSb

aThomas J. Stephens and Associates, Richardson, TX bRevision Skincare, Irving, TX

table 5

CONCLUSION

A 12-week clinical usage study was conducted to assess the long-term efficacy of a multi-ingredient anti-aging moisturizer in reducing the signs of aging of the facial skin. Limitations of the study include no vehicle control. The multi-ingredient anti-aging moisturizer was shown to be effective in reducing the signs of aging of the facial skin including fine lines and wrinkles, clarity/brightness, visual roughness, tactile roughness, evenness of skin tone (redness), evenness of skin tone (hyperpigmentation) and overall appearance after 8 and 12 weeks of twice daily use when compared to baseline scores. The subjects also liked the product and believed in the efficacy of the product as noted by the self-assessment questionnaire results. The statistically significant results provide medical professionals with information that could be beneficial when consulting a patient with signs of aging of the facial skin.

ACKNOWLEDGMENT

This study was 100% sponsored by Revision Skincare.

DISCLOSURES

Dr. Herndon and Dr. Jiang have no conflicts of interest to declare.Tatiana Kononov and Theresa Fox are employees of Revision Skincare

REFERENCES

  1. Elicidus Kurban RS, Bhawan J. Histologic changes in skin associated with aging. J Dermatol Surg Oncol. 1990;16(10):908-14.
  2. Sevimli-gür C, Onbaşılar I, Atilla P, et al. In vitro growth stimulatory and in vivo wound healing studies on cycloartane-type saponins of Astragalus genus. J Ethnopharmacol. 2011;134(3):844-50.
  3. Hong MJ, Ko EB, Park SK, Chang MS. Inhibitory effect of Astragalus membranaceus root on matrix metalloproteinase-1 collagenase expression and procollagen destruction in ultraviolet B-irradiated human dermal fibroblasts by suppressing nuclear factor kappa-B activity. J Pharm Pharmacol. 2013;65(1):142-8.
  4. Lintner K, Peschard O. Biologically active peptides: from a laboratory bench curiosity to a functional skin care product. Int J Cosmet Sci. 2000;22(3):207-18.
  5. Fournial A, Mondon P, Peschard O, inventors; Sederma, assignee. New compounds, in particular, peptides, compositions comprising them and cosmetic and dermo-pharmaceutical use. US patent 8697656 B2. April 15, 2014.
  6. Soo Lee Y, Jin DQ, Beak SM, Lee ES, Kim JA. Inhibition of ultraviolet-A-modulated signaling pathways by asiatic acid and ursolic acid in HaCaT human keratinocytes. Eur J Pharmacol. 2003;476(3):173-8.
  7. Farris PK. Topical vitamin C: a useful agent for treating photoaging and other dermatologic conditions. Dermatol Surg. 2005;31(7 Pt 2):814-7.
  8. Sauermann K, Jaspers S, Koop U, Wenck H. Topically applied vitamin C increases the density of dermal papillae in aged human skin. BMC Dermatol. 2004;4(1):13.
Close Menu